Fulgent Genetics, Inc.
NASDAQ:FLGT
22.27 (USD) • At close September 8, 2025
Overzicht | Financiële gegevens
| Bedrijfsnaam | Fulgent Genetics, Inc. |
| Symbool | FLGT |
| Munteenheid | USD |
| Prijs | 22.27 |
| Beurswaarde | 681,662,430 |
| Dividendpercentage | 0% |
| 52-weken bereik | 14.57 - 23.56 |
| Industrie | Diagnostics & Research |
| Sector | Healthcare |
| CEO | Mr. Ming Hsieh |
| Website | https://www.fulgentgenetics.com |
An error occurred while fetching data.
Over Fulgent Genetics, Inc.
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)





